Caption Management, LLC Assembly Biosciences, Inc. Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.13 - $3.46 $144,201 - $234,242	-67,700 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $70,022 - $86,970	-22,300 Reduced 24.78%	67,700 $236,000
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $342,000 - $410,399	90,000 New	90,000 $349,000
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $34,640 - $53,040	-8,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $29,220 - $103,740	-6,000 Reduced 42.86%	8,000 $47,000
Q3 2020 Nov 16, 2020	BUY	$15.08 - $27.04 $211,120 - $378,560	14,000 New	14,000 $230,000
Q4 2019 Feb 13, 2020	SELL	$8.36 - $23.81 $1.04 Million - $2.98 Million	-125,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $280,155 - $422,370	-28,500 Reduced 18.57%	125,000 $1.23 Million
Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $1.98 Million - $3.19 Million	153,500 New	153,500 $2.07 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.